{
    "Trade/Device Name(s)": [
        "VITROS XT Chemistry Products GLU-Ca Slides"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K190520",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182072",
        "K072440"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CGA",
        "CJY"
    ],
    "Summary Letter Date": "April 3, 2019",
    "Summary Letter Received Date": "March 4, 2019",
    "Submission Date": "February 28, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1145"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Calcium test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Calcium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS XT 7600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay",
        "Spectrophotometry"
    ],
    "Methodologies": [
        "Colorimetric measurement"
    ],
    "Submission Type(s)": [
        "Slide",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS XT Chemistry Products GLU-Ca Slides measuring glucose and calcium in multiple specimen types using colorimetric detection on VITROS XT 7600 Integrated System",
    "Indications for Use Summary": "For in vitro diagnostic use only; quantitatively measures glucose (GLU) in serum, plasma, urine, and CSF, and calcium (Ca) in serum, plasma, and urine to aid in diagnosis and treatment of disorders including diabetes, hypoglycemia, parathyroid disease, bone disease, and tetany",
    "fda_folder": "Clinical Chemistry"
}